Back

Right ventricular (RV) function assessment in PAH: why do we care?

31 August 2025 (15:17 - 15:23)
Organised by: Logo
Congress Presentation Part of: A new way to treat pulmonary arterial hypertension (PAH) that improves hemodynamics and right ventricular function Treatment Open Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Victor Moles

Ann Arbor (United States of America)

5 More presentations in this session

Presentation thumbnail
Welcome
Presentation thumbnail
A new pathway to treat PAH targeted by the first activin signaling inhibitor (ASI)
Doctor M. Escribano Subias (Madrid, ES)
Presentation thumbnail
Clinical data into context: effect of sotatercept on right ventricular (RV) function and structure
Doctor A. Vaidya (Temple, US)
Presentation thumbnail
Considerations on clinical implications
Professor S. Rosenkranz (Cologne, DE)
Presentation thumbnail
Q&A
Professor S. Rosenkranz (Cologne, DE)

Access the full session

Session thumbnail
A new way to treat pulmonary arterial hypertension (PAH) that improves hemodynamics and right ventricular function
Video

The Event

Event poster

ESC Congress 2025

31 August 2025 15:17 CET
You may be interested in
thumbnail
Congress Presentation
The Right Ventricle: pairing structural with functional assessment
29 June 2021
thumbnail
Webinar
Exercise and heart failure - role of the right ventricle
1 December 2025
thumbnail
Webinar
Focus on percutaneous short-term ventricular assist devices: joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices - Part 3. PVAD in right and biventricular failure
8 March 2022
thumbnail
Congress Session
Breaking the pressure: innovations in pulmonary hypertension management
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources